Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 5 | 2018 | 700 | 1.090 |
Why?
|
| Phenazopyridine | 1 | 2021 | 5 | 0.760 |
Why?
|
| Urinary Retention | 1 | 2021 | 20 | 0.740 |
Why?
|
| Mental Health Services | 2 | 2017 | 199 | 0.630 |
Why?
|
| Triage | 1 | 2017 | 109 | 0.550 |
Why?
|
| Rural Health Services | 1 | 2017 | 101 | 0.550 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 772 | 0.520 |
Why?
|
| Critical Care | 1 | 2017 | 263 | 0.500 |
Why?
|
| Punctures | 1 | 2015 | 35 | 0.490 |
Why?
|
| Cryotherapy | 1 | 2015 | 36 | 0.480 |
Why?
|
| Radial Artery | 1 | 2015 | 43 | 0.480 |
Why?
|
| Analgesia | 1 | 2015 | 58 | 0.470 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 711 | 0.470 |
Why?
|
| Crotalus | 1 | 2013 | 4 | 0.460 |
Why?
|
| Crotalid Venoms | 1 | 2013 | 6 | 0.460 |
Why?
|
| Hospitals, Community | 1 | 2014 | 64 | 0.460 |
Why?
|
| Snake Bites | 1 | 2013 | 7 | 0.460 |
Why?
|
| Ophthalmoplegia | 1 | 2013 | 20 | 0.460 |
Why?
|
| Pharyngeal Diseases | 1 | 2013 | 21 | 0.450 |
Why?
|
| Paralysis | 1 | 2013 | 35 | 0.450 |
Why?
|
| Facial Paralysis | 1 | 2013 | 25 | 0.450 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 114 | 0.430 |
Why?
|
| Pain | 1 | 2015 | 472 | 0.380 |
Why?
|
| Quality of Health Care | 1 | 2014 | 322 | 0.380 |
Why?
|
| Respiratory Dead Space | 1 | 2010 | 2 | 0.360 |
Why?
|
| Tidal Volume | 1 | 2010 | 17 | 0.360 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 78 | 0.350 |
Why?
|
| Child | 7 | 2017 | 6405 | 0.310 |
Why?
|
| Rhabdomyolysis | 2 | 2013 | 16 | 0.220 |
Why?
|
| Pediatrics | 2 | 2018 | 341 | 0.210 |
Why?
|
| Cystoscopy | 1 | 2021 | 23 | 0.190 |
Why?
|
| Respiration, Artificial | 2 | 2013 | 190 | 0.190 |
Why?
|
| Child, Preschool | 4 | 2017 | 3187 | 0.180 |
Why?
|
| Retrospective Studies | 3 | 2021 | 7277 | 0.180 |
Why?
|
| Infant | 3 | 2017 | 2891 | 0.170 |
Why?
|
| Humans | 11 | 2021 | 68618 | 0.160 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2455 | 0.160 |
Why?
|
| Societies, Medical | 2 | 2017 | 403 | 0.150 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2017 | 18 | 0.150 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 101 | 0.140 |
Why?
|
| Computers, Handheld | 1 | 2017 | 44 | 0.140 |
Why?
|
| Confidentiality | 1 | 2017 | 62 | 0.140 |
Why?
|
| School Health Services | 1 | 2017 | 72 | 0.140 |
Why?
|
| United States | 4 | 2018 | 7367 | 0.140 |
Why?
|
| Telephone | 1 | 2017 | 160 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 848 | 0.140 |
Why?
|
| Environment | 1 | 2017 | 115 | 0.140 |
Why?
|
| Informed Consent | 1 | 2017 | 127 | 0.140 |
Why?
|
| Patient Safety | 1 | 2017 | 202 | 0.130 |
Why?
|
| Child Abuse | 1 | 2017 | 186 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2017 | 383 | 0.130 |
Why?
|
| Adolescent | 4 | 2017 | 8912 | 0.120 |
Why?
|
| Age Factors | 2 | 2017 | 1864 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 951 | 0.120 |
Why?
|
| Crotoxin | 1 | 2013 | 3 | 0.120 |
Why?
|
| Infusions, Intraosseous | 1 | 2013 | 16 | 0.120 |
Why?
|
| Diphenhydramine | 1 | 2013 | 13 | 0.120 |
Why?
|
| Neuromuscular Junction | 1 | 2013 | 15 | 0.110 |
Why?
|
| Antivenins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2013 | 34 | 0.110 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2013 | 48 | 0.110 |
Why?
|
| Plasma | 1 | 2013 | 58 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 36 | 0.110 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2013 | 6 | 0.110 |
Why?
|
| Epinephrine | 1 | 2013 | 103 | 0.110 |
Why?
|
| Emergencies | 1 | 2013 | 107 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2021 | 3705 | 0.110 |
Why?
|
| Methylprednisolone | 1 | 2013 | 99 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1615 | 0.110 |
Why?
|
| Ant Venoms | 1 | 2013 | 8 | 0.110 |
Why?
|
| Ants | 1 | 2013 | 21 | 0.110 |
Why?
|
| Anaphylaxis | 1 | 2013 | 43 | 0.110 |
Why?
|
| Insect Bites and Stings | 1 | 2013 | 47 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2017 | 659 | 0.100 |
Why?
|
| Female | 3 | 2021 | 38074 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 117 | 0.100 |
Why?
|
| South Carolina | 1 | 2017 | 2752 | 0.090 |
Why?
|
| Capnography | 1 | 2010 | 1 | 0.090 |
Why?
|
| Male | 4 | 2017 | 37321 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 232 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2013 | 377 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 334 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2010 | 344 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 2279 | 0.060 |
Why?
|
| Animals | 2 | 2013 | 20881 | 0.040 |
Why?
|
| Biomedical Technology | 1 | 2018 | 14 | 0.040 |
Why?
|
| Financing, Organized | 1 | 2018 | 21 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 47 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2017 | 43 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2017 | 186 | 0.030 |
Why?
|
| Health Policy | 1 | 2018 | 221 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 502 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 138 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 581 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 204 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 255 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 89 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 1603 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5717 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 5731 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7029 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 21403 | 0.010 |
Why?
|